EcoDrugPlus

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSPNAG00000007705
Gene Symbol: LOC108424631
3 Cross references
378 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSPNAG00000024079
Gene Symbol: RXRA
3 Cross references
225 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSPNAG00000017438
Gene Symbol: LOC108439581
3 Cross references
225 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSPNAG00000014427
Gene Symbol: RPL10
3 Cross references
409 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSPNAG00000017943
Gene Symbol: RPL10A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSPNAG00000026061
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSPNAG00000023834
Gene Symbol: RPL12
3 Cross references
478 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSPNAG00000002916
Gene Symbol: RPL13
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSPNAG00000026887
Gene Symbol: RPL13A
3 Cross references
368 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSPNAG00000010165
Gene Symbol: RPL15
3 Cross references
77 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSPNAG00000009219
Gene Symbol: RPL17
3 Cross references
714 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSPNAG00000019682
Gene Symbol: RPL18
3 Cross references
379 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).